{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:24:30Z","timestamp":1782858270331,"version":"3.54.5"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.carres.2021.108326","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T11:50:44Z","timestamp":1620042644000},"page":"108326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19)"],"prefix":"10.1016","volume":"505","author":[{"given":"Monic","family":"Andrew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5729-2719","authenticated-orcid":false,"given":"Gurunathan","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carres.2021.108326_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carres.2021.108326_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-020-2169-0","article-title":"Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins","volume":"583","author":"Lam","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carres.2021.108326_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.5.2000062","article-title":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20\u201328 January 2020","volume":"25","author":"Backer","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.carres.2021.108326_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijid.2020.03.059","article-title":"Severe acute respiratory syndrome (SARS) and coronavirus disease-2019 (COVID-19): from causes to preventions in Hong Kong","volume":"94","author":"Law","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.carres.2021.108326_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/03602532.2020.1770782","article-title":"The broad-spectrum antiviral recommendations for drug discovery against COVID-19","volume":"52","author":"Hazafa","year":"2020","journal-title":"Drug Metabol. Rev."},{"key":"10.1016\/j.carres.2021.108326_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/v12050486","article-title":"Repurposing antiviral protease inhibitors using extracellular vesicles for potential therapy of COVID-19","volume":"12","author":"Kumar","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.carres.2021.108326_bib7","first-page":"2020","article-title":"Favipiravir versus Arbidol for COVID-19: a randomized clinical trial","author":"Chen","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.carres.2021.108326_bib8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carres.2021.108326_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Rosa","year":"2020","journal-title":"Rev. Panam. Salud P\u00fablic"},{"key":"10.1016\/j.carres.2021.108326_bib10","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carres.2021.108326_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/md18010005","article-title":"Marine pharmacology in 2014-2015: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, antiviral, and anthelmintic activities; affecting the immune and nervous systems, and other miscellaneous","volume":"18","author":"Mayer","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib12","doi-asserted-by":"crossref","first-page":"104373","DOI":"10.1016\/j.phrs.2019.104373","article-title":"Advances in exploring the therapeutic potential of marine natural products","volume":"147","author":"Liang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.carres.2021.108326_bib13","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3390\/md8102619","article-title":"Antiviral lead compounds from marine sponges","volume":"8","author":"Sagar","year":"2010","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib14","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1021\/cr4006318","article-title":"Role of marine natural products in the genesis of antiviral agents","volume":"115","author":"Gogineni","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.carres.2021.108326_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0975-7406.171700","article-title":"Exploring the ocean for new drug developments: marine pharmacology","volume":"8","author":"pdf","year":"2016","journal-title":"J. Pharm. BioAllied Sci."},{"key":"10.1016\/j.carres.2021.108326_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ddr.430230302","article-title":"Marine products as a source of antiviral drug leads","volume":"23","author":"T Che","year":"1991","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.carres.2021.108326_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/17460441.2019.1604675","article-title":"Have marine natural product drug discovery efforts been productive and how can we improve their efficiency?","volume":"14","author":"Pereira","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.carres.2021.108326_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijbiomac.2018.04.056","article-title":"The antiviral activity of polysaccharides and their derivatives","volume":"115","author":"Chen","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib19","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study","volume":"1","author":"Chu","year":"2020","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.carres.2021.108326_bib20","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carres.2021.108326_bib21","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.carres.2021.108326_bib22","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.carres.2021.108326_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1126\/scisignal.abf1117","article-title":"Cytoplasmic short linear motifs in ACE2 and integrin \u03b23 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy","volume":"14","author":"Kliche","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.carres.2021.108326_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071652","article-title":"COVID-19, renin-angiotensin system and endothelial dysfunction","volume":"9","author":"Amraei","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.carres.2021.108326_bib25","first-page":"15369","article-title":"Understanding SARS\u2010CoV\u20102 endocytosis for COVID\u201019 drug repurposing","author":"Glebov","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.carres.2021.108326_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Ysrafil, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes and Metabolic Syndrome: Clin. Res. Rev."},{"key":"10.1016\/j.carres.2021.108326_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.carres.2021.108326_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","author":"Benton","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carres.2021.108326_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-021-00523-5","article-title":"SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.carres.2021.108326_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","article-title":"The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19","volume":"39","author":"Yoshimoto","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.carres.2021.108326_bib31","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/bs.aivir.2016.08.008","article-title":"The nonstructural proteins directing coronavirus RNA synthesis and processing","author":"Snijder","year":"2016"},{"key":"10.1016\/j.carres.2021.108326_bib32","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cells9051267","article-title":"A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping","volume":"9","author":"Romano","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.carres.2021.108326_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.carres.2021.108326_bib34","doi-asserted-by":"crossref","first-page":"100847","DOI":"10.1016\/j.bbrep.2020.100847","article-title":"Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing","volume":"25","author":"Raj","year":"2021","journal-title":"Biochemistry and Biophysics Reports"},{"key":"10.1016\/j.carres.2021.108326_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43556-020-00001-4","article-title":"Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein","volume":"1","author":"Zhou","year":"2020","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.carres.2021.108326_bib36","doi-asserted-by":"crossref","first-page":"624765","DOI":"10.3389\/fchem.2020.624765","article-title":"Structural insight into the SARS-CoV-2 nucleocapsid protein C-terminal domain reveals a novel recognition mechanism for viral transcriptional regulatory sequences","volume":"8","author":"Yang","year":"2021","journal-title":"Frontiers in Chemistry"},{"key":"10.1016\/j.carres.2021.108326_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carres.2021.108326_bib38","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.cell.2020.07.033","article-title":"Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carres.2021.108326_bib39","series-title":"SARS-CoV-2, COVID-19 and Inherited Arrhythmia Syndromes","author":"Wu","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib40","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S0140-6736(20)30558-4","article-title":"Comorbidities and multi-organ injuries in the treatment of COVID-19","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.carres.2021.108326_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1008536","article-title":"The hallmarks of COVID-19 disease","volume":"16","author":"Tang","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.carres.2021.108326_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/kleuhsj.kleuhsj_116_20","article-title":"Acute kidney injury in patients with COVID-19","volume":"13","author":"Nerli","year":"2020","journal-title":"Indian Journal of Health Sciences and Biomedical Research (KLEU)"},{"key":"10.1016\/j.carres.2021.108326_bib43","first-page":"2020","article-title":"Causes of Death and Comorbidities in Patients with COVID-19","author":"Elezkurtaj","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.carres.2021.108326_bib44","article-title":"Arterial hypertension and the risk of severity and mortality of COVID-19","volume":"55","author":"Sisnieguez","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.carres.2021.108326_bib45","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"The BMJ"},{"key":"10.1016\/j.carres.2021.108326_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cytogfr.2020.05.001","article-title":"Understanding novel COVID-19: its impact on organ failure and risk assessment for diabetic and cancer patients","volume":"53","author":"Dariya","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.carres.2021.108326_bib47","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.carres.2021.108326_bib48","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","volume":"5","author":"Madjid","year":"2020","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.carres.2021.108326_bib49","first-page":"1","article-title":"Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2","author":"Robba","year":"2020","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.carres.2021.108326_bib50","series-title":"Pulmonary embolism in patients with Covid-19 pneumonia","first-page":"2001365","author":"Bompard","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.carres.2021.108326_bib52","doi-asserted-by":"crossref","first-page":"155404","DOI":"10.1016\/j.cyto.2020.155404","article-title":"Cytokine storm induced by SARS-CoV-2 infection: the spectrum of its neurological manifestations","volume":"138","author":"Thepmankorn","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.carres.2021.108326_bib53","series-title":"It's Not Just Lungs: Covid-19 May Damage the Heart, Brain, and Kidneys | Advisory Board Daily Briefing","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib54","doi-asserted-by":"crossref","first-page":"100042","DOI":"10.1016\/j.medidd.2020.100042","article-title":"Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19","volume":"6","author":"Kandasamy","year":"2020","journal-title":"Medicine in Drug Discovery"},{"key":"10.1016\/j.carres.2021.108326_bib55","series-title":"COVID-19 and Multiorgan Response, Current Problems in Cardiology","author":"Zaim","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib56","series-title":"COVID-19 Infection in People with Diabetes \u2013 touchENDOCRINOLOGY","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib57","series-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study, Lancet (London, England)","article-title":"UK Coronavirus Cancer Monitoring Project Team","author":"Lee","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib58","series-title":"\u2022 Pubpp","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib59","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1016\/S2214-109X(20)30204-7","article-title":"The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study","volume":"8","author":"Liu","year":"2020","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.carres.2021.108326_bib60","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cmi.2020.04.002","article-title":"Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre","volume":"26","author":"Peiffer-Smadja","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.carres.2021.108326_bib61","series-title":"Chloroquine: A Potential Drug in the COVID-19 Scenario","first-page":"1","author":"Singh","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib62","series-title":"FDA and WHO Drop Hydroxychloroquine from COVID-19 Treatment List","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib63","series-title":"WHO Warns Overuse of Antibiotics for Covid-19 Will Cause More Deaths","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105944","article-title":"Teicoplanin: an alternative drug for the treatment of COVID-19?","volume":"55","author":"Baron","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.carres.2021.108326_bib65","series-title":"Convalescent Plasma's Success against COVID-19 Continues in New Study - the Wire Science","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib66","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.carres.2021.108326_bib67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/ijmr.IJMR_585_20","article-title":"Perspectives for repurposing drugs for the coronavirus disease 2019","volume":"151","author":"Cherian","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.carres.2021.108326_bib68","doi-asserted-by":"crossref","first-page":"104228","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.carres.2021.108326_bib69","series-title":"Broad Anti-coronaviral Activity of FDA Approved Drugs against SARS-CoV-2 in Vitro and SARS-CoV in Vivo | bioRxiv","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.carres.2021.108326_bib71","series-title":"Experimental Virus Drug Remdesivir Failed in Human Trial (Update)","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib72","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.carres.2021.108326_bib73","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.carres.2021.108326_bib74","series-title":"Experimental Treatment with Favipiravir for COVID-19: an Open-Label Control Study, Engineering","author":"Cai","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib75","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00705-021-04956-9","article-title":"Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study","volume":"166","author":"Dabbous","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.carres.2021.108326_bib76","first-page":"1","article-title":"Tocilizumab, remdesivir, favipiravir, and dexamethasone repurposed for COVID-19: a comprehensive clinical and pharmacovigilant reassessment","volume":"2021","author":"Kelleni","year":"2021","journal-title":"SN Comprehensive Clinical Medicine"},{"key":"10.1016\/j.carres.2021.108326_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.carres.2021.108326_bib78","series-title":"A Rapid Review of Effectiveness in COVID-19 - CEBM","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib79","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carres.2021.108326_bib80","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jmv.25798","article-title":"Novel coronavirus treatment with ribavirin: groundwork for an evaluation concerning COVID-19","volume":"92","author":"Khalili","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.carres.2021.108326_bib81","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbrc.2004.11.128","article-title":"Ribavirin and interferon-\u03b2 synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines","volume":"326","author":"Morgenstern","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.carres.2021.108326_bib82","series-title":"Sofosbuvir as repurposed antiviral drug against COVID-19: why were we convinced to evaluate the drug in a registered\/approved clinical trial?","author":"Sayad","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijid.2020.05.085","article-title":"Lack of antiviral activity of darunavir against SARS-CoV-2","volume":"97","author":"De Meyer","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.carres.2021.108326_bib84","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.carres.2021.108326_bib85","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fimmu.2020.01061","article-title":"Interferon-\u03b12b treatment for COVID-19","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.carres.2021.108326_bib86","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carres.2021.108326_bib87","article-title":"COVID-19 and therapeutic drugs repurposing in hand: the need for collaborative efforts","author":"Khan","year":"2020","journal-title":"Pharmacien Hospitalier et Clinicien"},{"key":"10.1016\/j.carres.2021.108326_bib88","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41421-020-00192-8","article-title":"Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro","volume":"6","author":"Kwon","year":"2020","journal-title":"Cell Discovery"},{"key":"10.1016\/j.carres.2021.108326_bib89","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s12272-017-0958-2","article-title":"Marine polysaccharides: therapeutic efficacy and biomedical applications","volume":"40","author":"Lee","year":"2017","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.carres.2021.108326_bib90","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1089\/scd.2011.0521","article-title":"The sulfated polysaccharide fucoidan stimulates osteogenic differentiation of human adipose-derived stem cells","volume":"21","author":"Park","year":"2012","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.carres.2021.108326_bib91","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ygyno.2016.09.003","article-title":"In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel","volume":"143","author":"Novetsky","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.carres.2021.108326_bib92","article-title":"Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin derivatives","author":"Tandon","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.carres.2021.108326_bib93","doi-asserted-by":"crossref","first-page":"100623","DOI":"10.1016\/j.biteb.2020.100623","article-title":"Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: mini review","volume":"13","author":"Hans","year":"2021","journal-title":"Bioresource Technology Reports"},{"key":"10.1016\/j.carres.2021.108326_bib94","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/PL00011753","article-title":"Antiviral activities of marine pseudomonas polysaccharides and their oversulfated derivatives","volume":"1","author":"Matsuda","year":"1999","journal-title":"Mar. Biotechnol."},{"key":"10.1016\/j.carres.2021.108326_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-47917-8","article-title":"In vitro anti-HIV-1 activity of the bioactive compound extracted and purified from two different marine macroalgae (seaweeds) (Dictyota bartayesiana J.V.Lamouroux and Turbinaria decurrens Bory)","volume":"9","author":"Sanniyasi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.carres.2021.108326_bib96","first-page":"14","article-title":"Anti-viral activity of red microalgal polysaccharides against retroviruses","volume":"2","author":"Talyshinsky","year":"2002","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.carres.2021.108326_bib97","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.carbpol.2013.09.026","article-title":"Structure and anti-metapneumovirus activity of sulfated galactans from the red seaweed Cryptonemia seminervis","volume":"101","author":"Mendes","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib98","doi-asserted-by":"crossref","first-page":"1700748","DOI":"10.1002\/adhm.201700748","article-title":"Macromolecular antiviral agents against zika, Ebola, SARS, and other pathogenic viruses","volume":"6","author":"Schandock","year":"2017","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/j.carres.2021.108326_bib99","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.antiviral.2011.12.006","article-title":"In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03","volume":"93","author":"Kim","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.carres.2021.108326_bib100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/aid.1992.8.19","article-title":"Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro","volume":"8","author":"McCLURE","year":"1992","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.carres.2021.108326_bib101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2008.08.100","article-title":"Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga","volume":"376","author":"Hidari","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.carres.2021.108326_bib102","first-page":"2020","article-title":"Antiviral and virucidal activities of sulphated polysaccharides against Japanese encephalitis virus","author":"Rothan","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.carres.2021.108326_bib103","first-page":"164","article-title":"Structural features, molecular weight and anti-HSV activity of sulfated polysaccharides from three red seaweeds","volume":"8","author":"De Sousa","year":"2016","journal-title":"Journal of Chemical and Pharmaceutical Research"},{"key":"10.1016\/j.carres.2021.108326_bib104","first-page":"34","article-title":"Antiviral activity of sulfated polysaccharides carrageenan from some marine seaweeds","volume":"7","author":"Gomaa","year":"2016","journal-title":"International Journal of Current Pharmaceutical Review and Research"},{"key":"10.1016\/j.carres.2021.108326_bib105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/md14010004","article-title":"Characterization and comparison of the structural features, immune-modulatory and anti-avian influenza virus activities conferred by three algal sulfated polysaccharides","volume":"14","author":"Song","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib106","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijbiomac.2018.11.152","article-title":"Acidic polysaccharides isolated from marine algae inhibit the early step of viral infection","volume":"124","author":"Ueno","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.carbpol.2018.07.067","article-title":"Antiviral activity against enterovirus 71 of sulfated rhamnan isolated from the green alga Monostroma latissimum","volume":"200","author":"Wang","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib108","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/md11010020","article-title":"Nutritional and chemical composition and antiviral activity of cultivated seaweed sargassum naozhouense Tseng et Lu","volume":"11","author":"Peng","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/md9010139","article-title":"Sulfated polysaccharides in marine sponges: extraction methods and anti-HIV activity","volume":"9","author":"Esteves","year":"2011","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.carbpol.2011.07.026","article-title":"Sulfated polysaccharides from Laminaria angustata: structural features and in vitro antiviral activities","volume":"87","author":"Saha","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib111","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8502123","article-title":"Synergistic effects of sulfated polysaccharides from Mexican seaweeds against Measles virus","author":"Mor\u00e1n-Santiba\u00f1ez","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.carres.2021.108326_bib112","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2014.02.013","article-title":"Influence of sulphate on the composition and antibacterial and antiviral properties of the exopolysaccharide from Porphyridium cruentum","volume":"101","author":"Raposo","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.carres.2021.108326_bib113","doi-asserted-by":"crossref","first-page":"115280","DOI":"10.1016\/j.carbpol.2019.115280","article-title":"A sulfated glucuronorhamnan from the green seaweed Monostroma nitidum: characteristics of its structure and antiviral activity","volume":"227","author":"Wang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib114","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijbiomac.2012.05.028","article-title":"Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides","volume":"51","author":"Pujol","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1743-422X-9-307","article-title":"In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle Disease Virus","volume":"9","author":"Elizondo-Gonzalez","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.carres.2021.108326_bib116","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3390\/md9071187","article-title":"Antiviral activities of sulfated polysaccharides isolated from sphaerococcus coronopifolius (rhodophytha, gigartinales) and boergeseniella thuyoides (rhodophyta, ceramiales)","volume":"9","author":"Bouhlal","year":"2011","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib117","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.carres.2013.07.010","article-title":"The depolymerized fucosylated chondroitin sulfate from sea cucumber potently inhibits HIV replication via interfering with virus entry","volume":"380","author":"Huang","year":"2013","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.carres.2021.108326_bib118","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11802-012-1906-x","article-title":"Properties of polysaccharides in several seaweeds from Atlantic Canada and their potential anti-influenza viral activities","volume":"11","author":"Jiao","year":"2012","journal-title":"J. Ocean Univ. China"},{"key":"10.1016\/j.carres.2021.108326_bib119","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijbiomac.2017.04.043","article-title":"Green seaweed Enteromorpha compressa (Chlorophyta, Ulvaceae) derived sulphated polysaccharides inhibit herpes simplex virus","volume":"102","author":"Lopes","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijbiomac.2015.09.078","article-title":"In vitro anti-HIV-1 activity of fucoidan from Sargassum swartzii","volume":"82","author":"Dinesh","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib121","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/095632020901900603","article-title":"Sulfated xylomannans from the red seaweed Sebdenia polydactyla: structural features, chemical modification and antiviral activity","volume":"19","author":"Ghosh","year":"2009","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.carres.2021.108326_bib122","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijbiomac.2020.04.187","article-title":"Ulvan lyase assisted structural characterization of ulvan from Ulva pertusa and its antiviral activity against vesicular stomatitis virus","volume":"157","author":"Chi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib123","doi-asserted-by":"crossref","DOI":"10.1021\/np960017o","article-title":"Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis","volume":"59","author":"Hayashi","year":"1996","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.carres.2021.108326_bib124","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1248\/bpb.30.1573","article-title":"Anti-herpes simplex virus target of an acidic polysaccharide, nostoflan, from the edible blue-green alga nostoc flagelliforme","volume":"30","author":"Kanekiyo","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.carres.2021.108326_bib125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0141-8130(95)98157-T","article-title":"In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses","volume":"17","author":"Hasui","year":"1995","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/095632029600700403","article-title":"Antiviral activity of a sulphated polysaccharide extracted from the marine Pseudomonas and marine plant dinoflagellata against human immunodeficiency viruses and other enveloped viruses","volume":"7","author":"Hashimoto","year":"1996","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.carres.2021.108326_bib127","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1038\/s41598-019-47917-8","article-title":"In vitro anti-HIV-1 activity of the bioactive compound extracted and purified from two different marine macroalgae (seaweeds) (Dictyota bartayesiana J.V.Lamouroux and Turbinaria decurrens Bory)","volume":"9","author":"Sanniyasi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.carres.2021.108326_bib128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.carbpol.2016.01.065","article-title":"Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitro","volume":"143","author":"Wu","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.carbpol.2018.06.096","article-title":"The inhibitory effects and mechanisms of 3,6-O-sulfated chitosan against human papillomavirus infection","volume":"198","author":"Gao","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-5-107","article-title":"Iota-Carrageenan is a potent inhibitor of rhinovirus infection","volume":"5","author":"Grassauer","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.carres.2021.108326_bib131","doi-asserted-by":"crossref","first-page":"198150","DOI":"10.1016\/j.virusres.2020.198150","article-title":"Antibody-independent and dependent infection of human myeloid cells with dengue virus is inhibited by carrageenan","volume":"290","author":"Piccini","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.carres.2021.108326_bib132","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.jmb.2018.03.034","article-title":"Virus entry: looking back and moving forward","volume":"430","author":"Helenius","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.carres.2021.108326_bib133","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tim.2010.11.003","article-title":"Virus assembly, allostery and antivirals","volume":"19","author":"Zlotnick","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.carres.2021.108326_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.carres.2021.108326_bib135","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ijbiomac.2020.09.184","article-title":"The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica","volume":"163","author":"Jin","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib136","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/md9010139","article-title":"Sulfated polysaccharides in marine sponges: extraction methods and anti-HIV activity","volume":"9","author":"Esteves","year":"2011","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib137","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1371\/journal.ppat.0020069","article-title":"Carrageenan is a potent inhibitor of papillomavirus infection","volume":"2","author":"Buck","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.carres.2021.108326_bib138","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2012.11.006","article-title":"Novel polymeric inhibitors of HCoV-NL63","volume":"97","author":"Milewska","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.carres.2021.108326_bib139","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1134\/S1068162011050037","article-title":"Polyanionic inhibitors of HIV adsorption","volume":"37","author":"Baranova","year":"2011","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.carres.2021.108326_bib140","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-291X(91)91443-G","article-title":"N-Carboxymethylchitosan-N,O-sulfate as an anti-HIV-1 agent","volume":"174","author":"Sosa","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.carres.2021.108326_bib141","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijbiomac.2014.02.053","article-title":"Chemical characterization and antiherpes activity of sulfated polysaccharides from Lithothamnion muelleri","volume":"66","author":"Malagoli","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib142","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijbiomac.2019.06.129","article-title":"Assessment of antiherpetic activity of nonsulfated and sulfated polysaccharides from Azadirachta indica","volume":"137","author":"Faccin-Galhardi","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib143","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijbiomac.2019.05.005","article-title":"Chemically sulfated polysaccharides from natural sources: assessment of extraction-sulfation efficiencies, structural features and antiviral activities","volume":"136","author":"Mukherjee","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib144","article-title":"In vitro evaluation of antioxidant, anticancer, and antiviral activities of exopolysaccharide from Streptomyces hirsutus NRC2018 ARTICLE INFO","volume":"9","author":"El Awady","year":"2019","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.carres.2021.108326_bib145","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2174\/0929867043364504","article-title":"Sulfated seaweed polysaccharides as antiviral agents","volume":"11","author":"Damonte","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.carres.2021.108326_bib146","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.antiviral.2011.12.006","article-title":"In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03","volume":"93","author":"Kim","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.carres.2021.108326_bib147","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12250-010-3137-x","article-title":"In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis","volume":"25","author":"Chen","year":"2010","journal-title":"Virol. Sin."},{"key":"10.1016\/j.carres.2021.108326_bib148","first-page":"1","article-title":"Inhibition of influenza A virus infection by fucoidan targeting viral neuraminidase and cellular EGFR pathway","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.carres.2021.108326_bib149","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1039\/D0FO02017F","article-title":"Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2","volume":"11","author":"Song","year":"2020","journal-title":"Food and Function"},{"key":"10.1016\/j.carres.2021.108326_bib150","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.1016\/S0021-9258(19)50478-1","article-title":"The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides","volume":"267","author":"Batinic","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.carres.2021.108326_bib151","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00126334-199005000-00005","article-title":"Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy","volume":"3","author":"Baba","year":"1990","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.carres.2021.108326_bib152","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1248\/bpb.21.730","article-title":"An antivirally active sulfated polysaccharide from Sargassum horneri (Turner) C. Agardh,","volume":"21","author":"Hoshino","year":"1998","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.carres.2021.108326_bib153","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/md13020697","article-title":"Sulphated polysaccharides from Ulva clathrata and Cladosiphon okamuranus seaweeds both inhibit viral attachment\/entry and cell-cell fusion, in NDV infection","volume":"13","author":"Aguilar-Brise\u00f1o","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002188","article-title":"Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry\/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application","volume":"7","author":"Ichiyama","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.carres.2021.108326_bib155","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1021\/bi800205t","article-title":"Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1","volume":"47","author":"Copeland","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.carres.2021.108326_bib156","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/glycob\/cwn092","article-title":"Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation","volume":"19","author":"Ghosh","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.carres.2021.108326_bib157","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.3390\/md10122795","article-title":"The antiviral activities and mechanisms of marine polysaccharides: an overview","volume":"10","author":"Wang","year":"2012","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib158","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.phytochem.2010.11.006","article-title":"Structural features and in vitro antiviral activities of sulfated polysaccharides from Sphacelaria indica","volume":"72","author":"Bandyopadhyay","year":"2011","journal-title":"Phytochemistry"},{"key":"10.1016\/j.carres.2021.108326_bib159","first-page":"453","article-title":"Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds","author":"Shi","year":"2017","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.carres.2021.108326_bib160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4172\/jaa.1000023","article-title":"Anionic polysaccharides from phototrophic microorganisms exhibit antiviral activities to Vaccinia virus","volume":"2","author":"Radoni\u0107","year":"2010","journal-title":"J. Antivir. Antiretrovir."},{"key":"10.1016\/j.carres.2021.108326_bib161","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.carbpol.2015.12.005","article-title":"Structural characterization and antiviral activity of a novel heteropolysaccharide isolated from Grifola frondosa against enterovirus 71","volume":"144","author":"Zhao","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib162","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cyto.2008.07.009","article-title":"Innate immune response to viral infection","volume":"43","author":"Koyama","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.carres.2021.108326_bib163","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11357-020-00186-0","article-title":"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes","volume":"19","author":"Nikolich-Zugich","year":"2020","journal-title":"GeroScience"},{"key":"10.1016\/j.carres.2021.108326_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(20)30120-X","article-title":"The immunology of COVID-19: is immune modulation an option for treatment?","author":"Zhong","year":"2020","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.carres.2021.108326_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tifs.2019.08.008","article-title":"Sulfated polysaccharides: immunomodulation and signaling mechanisms","volume":"92","author":"Huang","year":"2019","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.carres.2021.108326_bib166","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/jam.12422","article-title":"Antiviral and immunomodulatory effects of a novel bacterial exopolysaccharide of shallow marine vent origin","volume":"116","author":"Gugliandolo","year":"2014","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.carres.2021.108326_bib167","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1039\/C8FO01946K","article-title":"The impacts of natural polysaccharides on intestinal microbiota and immune responses \u2013 a review","volume":"10","author":"Tang","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.carres.2021.108326_bib168","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijbiomac.2017.12.016","article-title":"Purification, structural features and immunostimulatory activity of novel polysaccharides from Caulerpa lentillifera","volume":"108","author":"Sun","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib169","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijbiomac.2018.11.244","article-title":"Synthesized sulfated and acetylated derivatives of polysaccharide extracted from Gracilariopsis lemaneiformis and their potential antioxidant and immunological activity","volume":"124","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fct.2019.03.042","article-title":"Chemistry and immunostimulatory activity of a polysaccharide from Undaria pinnatifida","volume":"128","author":"Yu","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.carres.2021.108326_bib171","doi-asserted-by":"crossref","first-page":"107245","DOI":"10.1016\/j.intimp.2020.107245","article-title":"Interferon-inducer antivirals: potential candidates to combat COVID-19","volume":"91","author":"Bagheri","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.carres.2021.108326_bib172","doi-asserted-by":"crossref","first-page":"384S","DOI":"10.1080\/07315724.2001.10719172","article-title":"Antioxidants and viral infections: host immune response and viral pathogenicity","volume":"20","author":"Beck","year":"2001","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.carres.2021.108326_bib173","first-page":"2014","article-title":"RNA viruses: ROS-mediated cell death","author":"Reshi","year":"2014","journal-title":"International Journal of Cell Biology"},{"key":"10.1016\/j.carres.2021.108326_bib174","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/rmv.303","article-title":"Role of free radicals in viral pathogenesis and mutation","volume":"11","author":"Akaike","year":"2001","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.carres.2021.108326_bib175","first-page":"1","article-title":"Emerging SARS - CoV - 2 mutation hot spots include a novel RNA - dependent - RNA polymerase variant","author":"Pachetti","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.carres.2021.108326_bib176","doi-asserted-by":"crossref","first-page":"110102","DOI":"10.1016\/j.mehy.2020.110102","article-title":"SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression","volume":"143","author":"Cecchini","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.carres.2021.108326_bib177","first-page":"1","article-title":"Sulfated polysaccharides and its commercial applications in food industries\u2014a review","author":"Muthukumar","year":"2020","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.carres.2021.108326_bib178","series-title":"Encyclopedia of Marine Biotechnology","first-page":"2619","article-title":"Marine\u2010origin polysaccharides for tissue engineering and regenerative medicine","author":"Reys","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib179","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/molecules25040930","article-title":"Extraction and modification of macroalgal polysaccharides for current and next-generation applications","volume":"25","author":"J\u00f6nsson","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.carres.2021.108326_bib180","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/antiox9050392","article-title":"Marine algal antioxidants as potential vectors for controlling viral diseases","volume":"9","author":"Sansone","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.carres.2021.108326_bib181","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/polym11071163","article-title":"Pharmacologic application potentials of sulfated polysaccharide from marine algae","volume":"11","author":"Manlusoc","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.carres.2021.108326_bib182","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.carbpol.2016.06.111","article-title":"Sulfated polysaccharide fraction from marine algae Solieria filiformis: structural characterization, gastroprotective and antioxidant effects","volume":"152","author":"Sousa","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib183","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.foodhyd.2017.08.002","article-title":"Chemical characterization and antioxidant activity of sulfated polysaccharides from Navicula sp","volume":"75","author":"Fimbres-Olivarria","year":"2018","journal-title":"Food Hydrocolloids"},{"key":"10.1016\/j.carres.2021.108326_bib184","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.foodhyd.2018.12.007","article-title":"A novel antioxidant sulfated polysaccharide from the algae Gracilaria caudata: in vitro and in vivo activities","volume":"90","author":"Alencar","year":"2019","journal-title":"Food Hydrocolloids"},{"key":"10.1016\/j.carres.2021.108326_bib185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4490\/algae.2017.32.12.1","article-title":"FTIR characterization and antioxidant activity of water soluble crude polysaccharides of Sri Lankan marine algae","volume":"32","author":"Shanura Fernando","year":"2017","journal-title":"ALGAE"},{"key":"10.1016\/j.carres.2021.108326_bib186","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijbiomac.2019.10.040","article-title":"Physicochemical characterization and antioxidant activity of sulphated polysaccharides derived from Porphyra haitanensis","volume":"145","author":"Khan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib187","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1080\/14786419.2017.1422183","article-title":"Anti-hydroxyl radical activity, redox potential and anti-AChE activity of Amanita strobiliformis polysaccharide extract","volume":"33","author":"Karaman","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.carres.2021.108326_bib188","series-title":"Solubility of Polysaccharides","first-page":"89","article-title":"Antioxidant activity of sulfated seaweeds polysaccharides by novel assisted extraction","author":"Wu","year":"2017"},{"key":"10.1016\/j.carres.2021.108326_bib189","doi-asserted-by":"crossref","first-page":"107881","DOI":"10.1016\/j.carres.2019.107881","article-title":"Structural features of microbial exopolysaccharides in relation to their antioxidant activity","volume":"487","author":"Andrew","year":"2020","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.carres.2021.108326_bib190","series-title":"Reviews on Mechanisms of in Vitro Antioxidant Activity of Polysaccharides, Oxidative Medicine and Cellular Longevity","author":"Wang","year":"2016"},{"key":"10.1016\/j.carres.2021.108326_bib191","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.carbpol.2012.07.075","article-title":"A sulfated polysaccharide, fucans, isolated from brown algae Sargassum vulgare with anticoagulant, antithrombotic, antioxidant and anti-inflammatory effects","volume":"91","author":"Dore","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib192","series-title":"Radiological Society of North America. \u201cNew Research Highlights Blood Clot Dangers of COVID-19.\u201d ScienceDaily","first-page":"13","author":"Yu","year":"2012"},{"key":"10.1016\/j.carres.2021.108326_bib193","series-title":"COVID Patients Are Getting Mysterious and Deadly Blood Clots","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib194","series-title":"Blood Clotting Abnormalities Reveal COVID-19 Patients at Risk for Thrombotic Events","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib195","series-title":"They Don't Struggle to Breathe\u2014But COVID-19 Is Starving Them of Oxygen","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib196","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7555\/JBR.29.20150121","article-title":"Platelets in hemostasis and thrombosis: novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis","volume":"29","author":"Hou","year":"2015","journal-title":"Journal of Biomedical Research"},{"key":"10.1016\/j.carres.2021.108326_bib197","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/md17030170","article-title":"Antithrombotics from the sea: polysaccharides and beyond","volume":"17","author":"Carvalhal","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21050551","article-title":"Polysaccharides from the marine environment with pharmacological, cosmeceutical and nutraceutical potential","volume":"21","author":"Ruocco","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.carres.2021.108326_bib199","series-title":"Marine Medicinal Foods","first-page":"195","article-title":"Chapter 12 - structure\u2013function relationship of anticoagulant and antithrombotic well-defined sulfated polysaccharides from marine invertebrates","author":"Pomin","year":"2012"},{"key":"10.1016\/j.carres.2021.108326_bib200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijbiomac.2020.05.012","article-title":"Sulfated polysaccharide from the red algae Gelidiella acerosa: anticoagulant, antiplatelet and antithrombotic effects","volume":"159","author":"Chagas","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2021.108326_bib201","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2017.178","article-title":"Targeting the Xa factor","author":"Starling","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.carres.2021.108326_bib202","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/md17040247","article-title":"Anticoagulant and antithrombotic properties in vitro and in vivo of a novel sulfated polysaccharide from marine green alga monostroma nitidum","volume":"17","author":"Cao","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib203","doi-asserted-by":"crossref","first-page":"101750","DOI":"10.1016\/j.algal.2019.101750","article-title":"Influence of sulfated polysaccharides from Ulva lactuca L. upon Xa and IIa coagulation factors and on venous blood clot formation","volume":"45","author":"Reis","year":"2020","journal-title":"Algal Research"},{"key":"10.1016\/j.carres.2021.108326_bib204","series-title":"Scientists Develop New Tool to Monitor Coronavirus Mutations - the Week","year":"2020"},{"key":"10.1016\/j.carres.2021.108326_bib205","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/biom9080340","article-title":"Vaccine adjuvants derived from marine organisms","volume":"9","author":"Sanina","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.carres.2021.108326_bib206","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00705-008-0047-4","article-title":"Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines","volume":"153","author":"Ghendon","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.carres.2021.108326_bib207","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1510264","article-title":"Vaccination with Astragalus and ginseng polysaccharides improves immune response of chickens against H5N1 avian influenza virus","author":"Abdullahi","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.carres.2021.108326_bib208","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1016\/j.vaccine.2018.07.040","article-title":"Polysaccharides as vaccine adjuvants","volume":"36","author":"Sun","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.carres.2021.108326_bib209","first-page":"4943","article-title":"Exopolysaccharide from Paecilomyces lilacinus modulates macrophage activities through the TLR4\/NF-\u03baB\/MAPK pathway","volume":"20","author":"He","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.carres.2021.108326_bib210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5582\/ddt.2015.01025","article-title":"Polysaccharides: candidates of promising vaccine adjuvants","volume":"9","author":"Li","year":"2015","journal-title":"Drug Discoveries & Therapeutics"},{"key":"10.1016\/j.carres.2021.108326_bib211","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1134\/S1063074016060055","article-title":"Prospects for the use of sulfated polysaccharides from brown seaweeds as vaccine adjuvants","volume":"42","author":"Kuznetsova","year":"2016","journal-title":"Russ. J. Mar. Biol."},{"key":"10.1016\/j.carres.2021.108326_bib212","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.vaccine.2010.05.068","article-title":"Carrageenan as an adjuvant to enhance peptide-based vaccine potency","volume":"28","author":"Zhang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.carres.2021.108326_bib213","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1038\/srep11062","article-title":"Antitumor and adjuvant activity of \u03bb-carrageenan by stimulating immune response in cancer immunotherapy","volume":"5","author":"Luo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.carres.2021.108326_bib214","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/molecules23020229","article-title":"Chemical modification of Chitosan for efficient vaccine delivery","volume":"23","author":"Xing","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.carres.2021.108326_bib215","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.vaccine.2019.06.003","article-title":"Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice","volume":"37","author":"Muralidharan","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.carres.2021.108326_bib216","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"ul Qamar","year":"2020","journal-title":"Journal of Pharmaceutical Analysis"},{"key":"10.1016\/j.carres.2021.108326_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/md18010050","article-title":"Antitumour potential of gigartina pistillata carrageenans against colorectal cancer stem cell-enriched tumourspheres","volume":"18","author":"Cotas","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.carres.2021.108326_bib218","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/07388551.2018.1472550","article-title":"Insight into carrageenases: major review of sources, category, property, purification method, structure, and applications","volume":"38","author":"Zhu","year":"2018","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.carres.2021.108326_bib219","series-title":"Seaweed Polysaccharides: Isolation, Biological and Biomedical Applications","first-page":"269","article-title":"Biomedical applications of fucoidan, seaweed polysaccharides","author":"Senthilkumar","year":"2017"},{"key":"10.1016\/j.carres.2021.108326_bib220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.carbpol.2011.12.029","article-title":"Biological activities and potential industrial applications of fucose rich sulfated polysaccharides and fucoidans isolated from brown seaweeds: a review","volume":"88","author":"Wijesinghe","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.carres.2021.108326_bib221","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.3390\/app10165488","article-title":"Ulvan, a polysaccharide from macroalga Ulva sp.: a review of chemistry, biological activities and potential for food and biomedical applications","volume":"10","author":"Cindana Mo\u2019o","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.carres.2021.108326_bib222","doi-asserted-by":"crossref","first-page":"101422","DOI":"10.1016\/j.algal.2019.101422","article-title":"Ulvan: a systematic review of extraction, composition and function","volume":"39","author":"Kidgell","year":"2019","journal-title":"Algal Research"},{"key":"10.1016\/j.carres.2021.108326_bib223","series-title":"Molecular Virology of Human Pathogenic Viruses","first-page":"31","article-title":"Virus life cycle","author":"Ryu","year":"2017"},{"key":"10.1016\/j.carres.2021.108326_bib224","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2013.11.002","article-title":"Concepts of papillomavirus entry into host cells","volume":"4","author":"Day","year":"2014","journal-title":"Current Opinion in Virology"},{"key":"10.1016\/j.carres.2021.108326_bib225","first-page":"155","article-title":"Receptors and routes of dengue virus entry into the host cells","volume":"39","author":"Cruz-Oliveira","year":"2015","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"key":"10.1016\/j.carres.2021.108326_bib226","series-title":"Progress in Molecular Biology and Translational Science","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.pmbts.2014.10.003","article-title":"The mechanism of HCV entry into host cells","author":"Douam","year":"2015"},{"key":"10.1016\/j.carres.2021.108326_bib227","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus\u2013host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.carres.2021.108326_bib228","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2217\/fmb.15.5","article-title":"Coxsackievirus B3 replication and pathogenesis","volume":"10","author":"Garmaroudi","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.carres.2021.108326_bib229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-0509-7-97","article-title":"A comprehensive map of the influenza A virus replication cycle","volume":"7","author":"Matsuoka","year":"2013","journal-title":"BMC Syst. Biol."}],"container-title":["Carbohydrate Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008621521000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008621521000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:23:55Z","timestamp":1757795035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008621521000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":229,"alternative-id":["S0008621521000951"],"URL":"https:\/\/doi.org\/10.1016\/j.carres.2021.108326","relation":{},"ISSN":["0008-6215"],"issn-type":[{"value":"0008-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19)","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carres.2021.108326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108326"}}